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Abstract
The gaseous free radical, nitric oxide (NO) acts as a ubiquitous neuromodulator, 
contributing to synaptic plasticity in a complex way that can involve either long term 
potentiation or depression. It is produced by neuronal nitric oxide synthase (nNOS) 
which is presynaptically expressed and also located postsynaptically in the membrane 
and cytoplasm of a subpopulation of each major neuronal type in the ventral cochlear 
nucleus (VCN). We have used iontophoresis in vivo to study the effect of the NOS 
inhibitor L‐NAME (L‐NG‐Nitroarginine methyl ester) and the NO donors SIN‐1 (3‐
Morpholinosydnonimine hydrochloride) and SNOG (S‐Nitrosoglutathione) on VCN 
units under urethane anaesthesia. Collectively, both donors produced increases and 
decreases in driven and spontaneous firing rates of some neurones. Inhibition of en-
dogenous NO production with L‐NAME evoked a consistent increase in driven firing 
rates in 18% of units without much effect on spontaneous rate. This reduction of gain 
produced by endogenous NO was mirrored when studying the effect of L‐NAME 
on NMDA(N‐Methyl‐D‐aspartic acid)‐evoked excitation, with 30% of units show-
ing enhanced NMDA‐evoked excitation during L‐NAME application (reduced NO 
levels). Approximately 25% of neurones contain nNOS and the NO produced can 
modulate the firing rate of the main principal cells: medium stellates (choppers), 
large stellates (onset responses) and bushy cells (primary‐like responses). The main 
endogenous role of NO seems to be to partly suppress driven firing rates associated 
with NMDA channel activity but there is scope for it to increase neural gain if there 
were a pathological increase in its production following hearing loss.
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1 |  INTRODUCTION
It has been suggested that homoeostatic mechanisms main-
tain firing rates throughout the auditory nervous system, such 
that, for example, the output from the ventral cochlear nu-
cleus (VCN) to the higher centres of the brain remains close 
to a long term average even when there are fluctuations in 
the peripheral input (Noreña, 2011; Schaette & McAlpine, 
2011). However, the details of the neural mechanisms in-
volved are unknown (Auerbach et al., 2014).
Homoeostatic plasticity is mediated by neuromodula-
tors such as nitric oxide (NO) which facilitate or suppress 
the strength of synaptic transmission (Steinert et al., 2011). 
The NO‐forming enzyme, NOS has three main isoforms: an 
inducible form which is present in reactive glial cells, but 
which is not present in the control, healthy VCN (Coomber, 
Kowalkowski, Berger, Palmer, & Wallace, 2015) and two 
calcium‐dependent isoforms that are located in either en-
dothelial cells (eNOS) or some neurones (nNOS). The en-
dothelial eNOS is mainly involved in controlling vascular 
tone, but may provide a uniform background level of NO 
that determines the baseline levels of nearby neurones 
(Garthwaite, 2008). The nNOS has been identified in many 
stages of the auditory system, from the cochlea through 
the cochlear nucleus, superior olivary complex (SOC) and 
inferior colliculus to the auditory cortex (Baizer et  al., 
2014; Burette, Petrusz, Schmidt, & Weinberg, 2001; Coote 
& Rees, 2008; Eliasson, Blackshaw, Schell, & Snyder, 
1997; Fessenden, Altschuler, Seasholtz, & Schacht, 1999; 
Fessenden, Coling, & Schacht,1994; Lee, Cho, Huh, 
Cha, & Yeo, 2008; Rodrigo et al., 1994). The presence of 
nNOS throughout the auditory system suggests that NO 
contributes significantly to auditory processing and that 
it does so in a number of ways. NO has been shown to 
modulate postsynaptic excitability at the medial nucleus 
of the trapezoid body (MNTB; Steinert et al., 2008, 2011), 
to reduce the activity of the neuronal potassium–chloride 
cotransporter in the superior paraolivary nucleus (Yassin 
et al., 2014) and to affect the efficiency of IH currents in 
the SOC nuclei (Kopp‐Scheinpflug, Pigott, & Forsythe, 
2015). NO also has a role in the NMDA‐dependant poten-
tiation of synapses in a polysynaptic network of chopper 
cells (T‐stellate) in the VCN (Cao, Lin, Sugden, Connors, 
& Oertel, 2019).
nNOS is present both in the spiral ganglion neurones that 
provide the afferent innervation to the VCN (Zdanski et al., 
1994) and in the VCN projection neurones. These are the 
globular and spherical bushy cells, which show primary‐like 
peri‐stimulus time histograms (PSTHs; Smith & Rhode, 
1987); small‐ to medium‐sized stellate cells, with chop-
per PSTHs (Palmer, Wallace, Arnott, & Shackleton, 2003; 
Smith & Rhode, 1989); and large stellate cells and octopus 
cells (OC) with distinctive onset responses (Arnott, Wallace, 
Shackleton, & Palmer, 2004; Oertel, Wu, Garb, & Dizack, 
1990; Rhode, Oertel, & Smith, 1983). The afferent inputs 
from the auditory nerve and the majority of VCN neurones 
with intrinsic branches are excitatory, while the large stellate 
onset cells and some small chopping stellates are glycinergic 
(Doucet, Ross, Gillespie, & Ryugo, 1999; Ngodup & Trussell, 
2019). All of these intrinsic neurones can contain nNOS, but 
within each class there are large variations in the quantity 
of enzyme present (Coomber et  al., 2015). Recent work in 
the inferior colliculus has indicated that nNOS may either be 
distributed throughout the cytoplasm or have a punctate dis-
tribution on the surface of neurones and be associated with 
NMDA receptors at the postsynaptic density (Olthof‐Bakker, 
Gartside, & Rees, 2019). This may also be true in the VCN.
Various manipulations of peripheral afferent input have 
been used to study NO in the auditory system. Cochleotomy, 
resulting in hugely decreased input, produces decreased spon-
taneous firing rates (Koerber, Pfeiffer, Warr, & Kiang, 1966) 
and increased nNOS expression (Chen, Huang, Wang, & Chen, 
2004) in the VCN, primarily by a redistribution of nNOS from 
being mostly in the cytoplasm to being mostly associated with 
NMDA receptors in the membrane. Other less traumatic periph-
eral alterations such as acoustic over exposure (Alvarado et al., 
2016; Coomber et al., 2014) also result in increases to cochlear 
nucleus nNOS expression. Following noise exposure, changes 
in nNOS are correlated with behavioural evidence of tinnitus 
(Coomber et al., 2014). As NO can alter synaptic plasticity, it 
may have a role in the gain changes that have been suggested 
as a potential mechanism underlying tinnitus (Noreña, 2011).
Such data have led to the postulate that NO levels in 
the VCN are involved in homoeostatic plasticity (Coomber 
et al., 2015). To test this hypothesis, we have used the ion-
tophoretic application of a NOS inhibitor and two NO do-
nors, while recording from identified single units in vivo. 
For the inhibitor we used L‐NAME which is a water‐solu-
ble, non‐selective inhibitor that is suitable for iontophoresis 
(Carletti, Ferraro, Rizzo, Friscia, & Sardo, 2012). Initially, 
we used SIN‐1 as an NO donor as it has often been used 
successfully for in vivo studies in the past (Galati et  al., 
2008). However, like NOS itself, SIN‐1 is not a pure source 
of NO as its decomposition produces equal amounts of NO 
and the superoxide ion that combines to form peroxynitrite 
(Feelisch, Ostrowski, & Noack, 1989). The peroxynitrite can 
then either oxidize sensitive cellular components or lead to 
an active intermediate by reacting with glutathione to pro-
duce SNOG which can then release NO to activate guanylyl 
cyclase (Schrammel, Pfeiffer, Schmidt, Koesling, & Mayer, 
1998). Thus we also used the iontophoresis of SNOG di-
rectly as it has been shown to be an effective source of NO 
when iontophoresed onto neurones in other parts of the brain 
(Carletti et al., 2012).
If NO is specifically involved in modulating neuronal 
firing rates, then both the inhibitor and donors should be 
   | 3HOCKLEY Et aL.
effective, and their effects may vary depending on whether 
or not the neurone is acoustically driven. Much of our infor-
mation about NO action has derived from slice preparations 
which involved electrical stimulation and which typically 
were allowed to equilibrate for up to an hour. As Steinert 
et al. (2011) demonstrate, much of the endogenous nitrergic 
action may be lost in this hour. Here we used an intact in 
vivo preparation that has allowed precisely timed, physiolog-
ical sensory stimulation (acoustic tones presented to the ear) 
combined with extremely local application of NO donors and 
an inhibitor (by iontophoresis directly onto the target cell) 
and the ability to define (by physiological profile at least) the 
cell type under study. Thus, the data we present here should 
represent a valid demonstration of the type of effects that re-
sult from nitrergic action during mild stimulation.
2 |  MATERIALS AND METHODS
All procedures were carried out under authority of the UK 
Home Office under the Animals (Scientific Procedures) Act 
1986. Experiments were run in accordance with the European 
Communities Council Directive 1986 (86/609/EEC) and the 
approval of the Animal Welfare and Ethical Review Body at 
the University of Nottingham, UK.
2.1 | Animals
Male and female tricolour guinea pigs weighing 400–1,200 g 
were used. For each experimental procedure applied to a 
group, we attempted to use roughly equal numbers of animals 
of each sex. However, as we were using animals from our 
own small colony and did not want to cull animals, there was 
sometimes an imbalance in the numbers of each sex. Guinea 
pigs were group‐housed in floor pens or large, well‐venti-
lated cages with environmental enrichment (cardboard tubes, 
plastic houses and wooden gnawing blocks) on a 12/12  hr 
light‐dark cycle, with food and water readily available.
2.2 | Histology
Stained sections showing nNOS were available from our 
previous study of the effect of noise exposure on NOS ex-
pression in the VCN (Coomber et al., 2015). Sections were 
cut at 50  μm and endogenous peroxidase removed by im-
mersing in phosphate buffer (100  mM, pH 7.4) containing 
0.3% H2O2 and 10% methanol, followed by phosphate buffer 
containing 5% normal horse serum (NHS) and 0.5% Triton 
X‐100. Sections were then incubated with monoclonal anti‐
nNOS primary antibody (1:2,000; N2280, Sigma) in buffer 
containing 5% NHS and 0.5% Triton X‐100 overnight at 4°C. 
Subsequently, sections were washed (3 × 10 min in buffer), 
before incubation with biotinylated anti‐mouse secondary 
antibody (1:100; Vector Laboratories, UK) for 2 hr at room 
temperature. Sections were then washed and incubated in 
buffer containing Vectastain ABC Elite solution (Vector 
Laboratories) and 1% NHS. After a further series of washes, 
the sections were placed in 0.05% diaminobenzidine tetrahy-
drochloride (DAB) solution, in buffer, for 10 min, followed 
by a solution of 0.001% hydrogen peroxide in DAB solution 
for an additional 10 min. The sections were then washed in 
buffer to halt the DAB reaction, mounted on coated slides, 
air‐dried, dehydrated and cover‐slipped. These were re‐ex-
amined to study the distribution of nNOS staining and deter-
mine if it was associated with postsynaptic densities in the 
same way as for the inferior colliculus (Olthof‐Bakker et al., 
2019). We also separately stained 50 μm sections for Nissl 
substance with a standard cresyl violet stain (0.5% dissolved 
in 0.2 M acetate buffer at pH 3.9) to allow comparison of the 
density of neurones in the VCN. In addition, we compared 
the nNOS stained VCN sections with those loaded with che-
lated thallium ions to indicate the levels of potassium uptake 
and associated neuronal activity (Goldschmidt et al., 2010). 
In two control animals, the external jugular vein was can-
nulated under deep urethane anaesthesia. A freshly prepared 
solution of thallium chelated with diethyldithiocarbamate 
consisting of 3 ml of a 0.2% suspension was injected into the 
vein over a period of 3 min and flushed through with physi-
ological saline. The animals were then given a lethal dose of 
pentobarbitone (i.v.) 2 min later and the brains prepared for 
autometallography as described previously (Coomber et al., 
2011). Coronal sections (50 μm) were cut through the VCN 
and processed to demonstrate the presence of thallium ions 
(Goldschmidt et al., 2010).
2.3 | Surgery
Guinea pigs were anaesthetized with 20% w/v urethane 
(4.5  ml/kg i.p.; Sigma) and Hypnorm solution (fentanyl/
fluanisone; 0.2  ml i.m.). Further injections of Hypnorm of 
up to 0.2 ml i.m. were administered when required to main-
tain surgical anaesthesia. Guinea pigs were artificially res-
pirated with 100% oxygen (tidal volume 3.5 ml, respiratory 
rate 100 per minute) and the temperature was maintained at 
38 ± 0.5°C. Guinea pigs were placed within a sound‐attenu-
ating and electrically earthed chamber, positioned in a stere-
otaxic frame with hollow speculae lined up to the tympanic 
membrane. The skull was exposed and levelled between 5 
and 13 mm anterior to ear bar zero (Rapisarda & Bacchelli, 
1977). An insect pin was attached along the centre of the 
skull to mark the midline. The skull over the left cerebel-
lum was removed by the use of an electric drill and rongeurs 
at between 1 and 5  mm lateral to the midline. Dura mater 
was excised and the exposed brain surface was kept moist by 
regular application of warm 0.9% saline or by a layer of agar 
(1.5% solution in 0.9% saline).
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2.4 | Sound presentation
Experiments were carried out in a sound‐attenuated chamber. 
Auditory stimuli were delivered monaurally via a closed‐field 
system (modified Radioshack 40‐1377 tweeters; M. Ravicz, 
Eaton Peabody Laboratory) coupled to damped 4‐mm‐diam-
eter probe tubes, which fitted into the hollow earbars. The 
speakers were driven by a Tucker–Davis Technologies (TDT) 
System 3 (RZ2), controlled by Brainware (software devel-
oped by J. Schnupp, University of Oxford, UK). A probe tube 
microphone (Brűel and Kjaer 4134 with a calibrated 1‐mm 
probe tube) was used to calibrate the sound system close to 
the tympanic membrane. The sound system response was 
flat to within ±10 dB from 100 to 35,000 Hz (see Palmer & 
Shackleton, 2009 for an example calibration curve).
2.5 | Iontophoresis
Extracellular drug application was achieved using five‐bar-
relled glass micropipettes (5B120F‐4; World Precision 
Instruments (WPI)). These were pulled with a microelec-
trode puller and the tips broken back to a width of 20 μm 
under a microscope using a glass ball. A taper‐to‐tip length 
of 10–15 mm was optimal to achieve the desired resistance 
and to reach the cochlear nucleus. Glass‐coated tungsten 
recording electrodes with a tip length of 10 μm were made 
in‐house (Bullock, Palmer, & Rees, 1988) and glued to the 
micropipette using 5‐min epoxy resin, with the tip extending 
20–30  μm beyond the pipette barrels in order to minimize 
damage at the recording site.
The drug barrels of the 5‐barrelled glass pipette were filled 
with either Nω‐Nitro‐L‐arginine methyl ester hydrochloride 
(L‐NAME, 50 mM, pH 6.5), 3‐Morpholinosydnonimine hy-
drochloride (SIN‐1, 40  mM, pH 4.5), N‐Methyl‐D‐aspartic 
acid (NMDA, 10 mM, pH 8) and glutamate (100 mM, pH 8), 
all obtained from Sigma and dissolved in distilled water, or 
S‐Nitrosoglutathione (SNOG, 15 mM, pH 4.5 obtained from 
Abcam [ www.abcam.com]). Retaining currents of 10  nA 
were applied to drug barrels between ejections, with polarity 
opposite to the charge of the drug to be ejected. Retaining 
currents were positive for NMDA and glutamate and negative 
for L‐NAME, D‐NAME, SNOG and SIN‐1.
The central barrel was filled with 2 M NaCl solution, to 
allow current balancing, with the remaining barrels filled with 
drugs. Cycling was used to maintain drug concentrations at 
the electrode tip between recordings, where each drug barrel 
would be supplied with the ejection current for 8 s every 36 s. 
All currents were applied by a Neurophore (Digitimer) BH‐2 
iontophoresis system, consisting of four IP‐2 iontophoretic 
pump modules and one BM‐2 control and balance module.
Each time a new electrode assembly was inserted into the 
brain, we checked that the assembly was working properly by 
recording from and stimulating a cerebellar neurone. Once a 
unit was isolated, ejection currents were applied to the gluta-
mate barrel. An excitation response suggested that the ionto-
phoresis set‐up was functioning correctly. The iontophoresis 
assembly was then advanced into the VCN and, after neu-
ronal identification, experiments involving drug application 
begun.
2.6 | Recordings
Electrodes were advanced through the cerebellum to the 
cochlear nucleus at a 45° angle using a Burleigh Inchworm 
stepping motor (Burleigh Instruments). The VCN was lo-
cated stereotaxically, 3.5–4.5 mm lateral of midline, ±1 mm 
anterior/posterior of ear bar zero and 0–2 mm dorsal of ear 
bar zero.
The single‐channel recording electrode was connected 
through an HS‐2 headstage (×1  L; Axon Instruments Inc.) 
and an Axoprobe‐1A microelectrode amplifier (×100; Axon 
Instruments Inc.) then further amplified ×100 (IHR 4 Channel 
Amplifier). The resulting signal then passed to a TDT System 
3, RZ2 processor for filtering (0.3–3 kHz), and online data 
collection was facilitated by Brainware at a sampling rate of 
25 kHz. Spikes were detected online in Brainware by an arbi-
trarily set threshold, never less than double the peak‐to‐peak 
amplitude of the background noise to keep the risk of false 
positives at less than 5%.
2.7 | Analyses
Upon isolation of a single unit based on spike height/wave-
form, the sound frequency at the minimum threshold was de-
termined (characteristic frequency: CF) to confirm that the 
new unit had a CF that was different by at least one octave 
from the CF of the previous unit in the track, where drugs 
had been applied. Units were only analysed if they were at 
least 300 μm from a previous unit in the same track to mini-
mize the risk of any previously applied drugs still having a 
residual effect. Single units were classified into one of five 
subgroups: primary‐like (Pr), chopper (Ch), phase‐locked 
(Ph), onset (On) or unclassified (Un) based on PSTHs to 
50‐ms CF tones at 20 dB suprathreshold. Primary‐like units 
have temporal discharge patterns like those of primary au-
ditory nerve fibres showing a stochastic discharge, which is 
maximal at onset and then adapts to a steady state: chopper 
units show preferred firing times resulting in regularly occur-
ring spikes and peaks in their PSTH: Onset units show one 
or two peaks at the onset of their PSTH with low sustained 
firing rates thereafter. Phase locking occurs in response to 
low‐frequency sinusoids and in low‐CF units often obscures 
the shape of the PSTH preventing definite allocation to pri-
mary‐like, chopper or onset types (Arnott et al., 2004; Palmer 
et al., 2003; Rhode et al., 1983; Smith & Rhode, 1989).
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Hour‐long, pure‐tone pulse trains were then presented at 
the characteristic frequency (200 ms tone pip, 800 ms silence, 
3,600 repeats). Spike timings throughout the sweep were re-
corded, allowing offline analysis of the auditory‐driven firing 
rate (initial 200 ms) or spontaneous firing rate (final 700 ms). 
Spike timings that occurred within 100 ms following the off-
set of the tone pip were not included in analysis, in order to 
allow for poststimulus recovery of spontaneous activity.
2.8 | Drug ejection periods and 
statistical analysis
SIN‐1 and SNOG were applied for 10 min, three separate times 
over an hour, using increasing ejection currents of 40, 80 and 
120 nA at 10–20, 25–35 and 40–50 min, respectively (Figure 1). 
Spike rates were computed in 10 s epochs at the following time 
points: the final 2 min of baseline prior to drug ejection (base-
line: B), the final 2 min during each drug ejection (shown in 
yellow (E) in Figure 1) and the final 2 min of each recovery 
period (recovery: R1, R2 and R3). In chronological order, the 
seven analysis periods were: B, 40 nA, R1, 80 nA, R2, 120 
nA and R3. Analysis periods were compared using a Kruskal–
Wallis test with Dunn's multiple comparison test and responses 
were deemed significant if there was a significant change from 
R1—80 nA and R2—120 nA in the same direction, and a sig-
nificant return towards baseline from 120 nA—R3.
L‐NAME was applied at 80 nA for 20 min (from 15 to 
35 min) during an hour‐long recording (Figure 1). Pilot stud-
ies had shown that the build‐up of an effect of blocking nNOS 
activity had a slower time course than either of the NO do-
nors. Spike rates were measured over 60  s epochs, and the 
final 10 min of drug ejection (shown yellow (E) in Figure 1) 
was compared with both the final 10 min of baseline (B) and 
the final 10 min of the recording (R) using a Kruskal–Wallis 
test with Dunn's multiple comparison test. If both compar-
isons showed significant changes in the same direction, the 
unit firing rate was deemed to have changed by a statistically 
significant degree.
The effect of L‐NAME on NMDA‐mediated excitation was 
measured during a 1‐hr tone pulse train. NMDA was applied 
at 80 nA for 1 min every 2 min between 10 and 20 min, 30 
and 40 min and 50 and 60 min, while L‐NAME was applied 
at 80 nA from 20 to 40 min (Figure 1). This gave one baseline 
period of NMDA responses (B), one period of responses in the 
presence of L‐NAME (yellow (E) in Figure 1) and one recov-
ery period (R). With these data in 10 s bins, the six bins with 
highest spike rate from the final three NMDA applications of 
each period were used. The baseline firing rate (mean of 180 s 
before the initial NMDA application of that period) was used 
to calculate the percentage change in firing rate evoked by 
NMDA. These increases for each period were compared using 
a Kruskal–Wallis test with Dunn's multiple comparison test.
2.9 | Spike shape and phase‐locking analysis
The mean spike shape for each sweep (1 s) was calculated, 
from which the peak‐to‐peak amplitude and width at half 
amplitude were measured and plotted over the recording pe-
riod. For statistical analysis, data were binned as before, over 
1  min for L‐NAME and over 10  s for NO donors. Again, 
comparisons between analysis periods were made using a 
Kruskal–Wallis test with Dunn's multiple comparison test.
The strength and timing of phase locking in phase‐locked 
units was analysed for each analysis period by the vector 
strength method (Goldberg & Brown, 1969). The distribution 
of spikes in the period histogram (locked to a single period 
of the stimulus waveform) derived from each analysis inter-
val was compared using a two‐sample Kolmogorov–Smirnov 
test. If phase locking during drug application was signifi-
cantly different from baseline and recovery, and baseline and 
recovery were not significantly different, the phase locking of 
the unit was judged to have been altered.
F I G U R E  1  The timing of drug applications (red and green blocks) and response measurements. For statistical analysis in all iontophoresis 
experiments, yellow blocks labelled (E) show periods in which the response to the drugs were measured, blue blocks labelled (B) show baseline 
intervals and those labelled (R) show recovery intervals
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3 |  RESULTS
3.1 | nNOS histology
We examined the antibody staining against nNOS in the 
VCN. The staining intensity varied greatly between neurones 
of the same type with some being lightly stained and some 
being as intensely stained as any found in other parts of the 
brainstem. Staining was present in the somata, but also ex-
tended well into the dendrites. Most were cytoplasmic, but 
there was also evidence of discrete particles that were associ-
ated with the postsynaptic membrane. This particulate stain-
ing was found in all cell types and examples are indicated by 
small black arrows in Figure 2a,b on the dendrites of an OC 
and on multipolar cells (MC) as well as the soma of a globular 
bushy cell (GC). Specific staining was also present in small 
structures that appeared to be axonal swellings (large arrow-
heads in Figure  2c). Thus, in VCN nNOS may be located 
either presynaptically, postsynaptically or in the cytoplasm 
of some cells, but not others. Not all neurones contained 
nNOS as some were completely unstained. An indication 
of the proportion of neurones stained is shown by compar-
ing a low magnification view of the VCN stained for nNOS 
(Figure 2h) with a Nissl stained section (Figure 2g). Some 
of the neurones are small granule cells that form a granule 
cell cap over the dorsal aspect of VCN (gr), but these cells 
do not contain detectable levels of nNOS. We also used the 
neuronal marker thallium to look at the number and staining 
variability of neurones in the VCN (Figure 2i). There were 
more thallium stained neurones than were stained with the 
nNOS, but like the nNOS, the level of staining was very vari-
able with some neurones having taken up a large amount of 
thallium and being darkly stained, while others had taken up 
a small amount of thallium in the loading period and were 
lightly stained. Comparisons of neuronal numbers stained by 
the three methods were made by making counts on five cor-
responding sections from each of two different brains stained 
with each method (six brains in all). These gave a ratio of 
approximately 4 Nissl: 2 thallium: 1 nNOS (1885: 1060: 
513).
In Figure 2a,b a photograph of a typical electrode assem-
bly is shown at the same magnification as the stained cells 
to give an impression of how locally the drugs would be re-
leased in this study. The white outlined arrow in Figure 2b 
shows the 10 μm tip of exposed tungsten wire extending be-
yond the glass insulation. About 30  μm further back from 
these are the five barrels of the attached micropipettes used 
for drug administration. With this arrangement, the soma of 
the recorded neurone should be exposed to relatively high 
concentrations of drug when they are released iontophoret-
ically. Examples of the spikes recorded by a tungsten elec-
trode of one of these assemblies are shown in Figure 2f for 
a globular cell that shows a primary‐like with a notch firing 
pattern. By using the stain NADPH‐diaphorase (reduced nic-
otinamide adenine dinucleotide phosphate diaphorase) it is 
possible to visualize all three isoforms of NOS if they are 
present in a tissue. In addition to the neuronal staining such 
as the globular bushy cells (large arrowheads in Figure 2d) 
and MC (Figure 2d black arrows), there are also small dense 
patches of endothelial NOS associated with the lining of the 
blood vessels that densely permeate the VCN. These blood 
vessels are indicated (Figure 2e) by the red overlay that has 
been superimposed on the same micrograph as shown in 
Figure 2d. Thus although the NO released from a neurone or 
exogenous chemical can diffuse readily in the tissue it will 
rapidly encounter a blood vessel where it will be inactivated 
by binding to haemoglobin. The dense arrangement of blood 
vessels appears to form micro‐compartments where there are 
neurones with low levels of NADPH‐diaphorase (white ar-
rows in Figure 2d) that are isolated from the neurones with 
relatively high levels of staining. There was no evidence of 
NADPH‐diaphorase staining in either astrocytes or microg-
lia which is where the inducible form of NOS (iNOS) would 
be found if there was any pathological damage (Wallace & 
Bisland, 1994).
F I G U R E  2  Local environment of neurones containing nNOS in the VCN. (a) The nNOS staining is associated with a number of structures 
and can produce dense cytoplasmic staining in the soma such as the octopus cell (OC) but it also forms distinct clumps that seem to be associated 
with the postsynaptic membrane of both somata and dendrites as indicated by black arrows on the octopus cell (OC) dendrites and globular 
bushy cell soma (GC). These cells are shown at higher power in panel a*. (b) The nNOS staining is also associated with discrete particles on 
the membrane of multipolar cells (MC, black arrows). Some of these particles are shown at higher power in panel b*. A photomicrograph of the 
electrode assembly is shown superimposed on the section and the tip of the tungsten recording electrode is shown by the white arrow. (c) Specific 
nNOS staining was also observed in small clumps that appear to be axonal swellings and examples are indicated by black arrowheads. (d, e) Show 
the same coronal section through VCN stained for NADPH‐diaphorase which indicates the presence of all three isoforms of NOS. The large 
arrowheads indicate darkly stained globular bushy cells while the black arrows indicate darkly stained multipolar cells. The red overlay indicates 
the presence of blood vessels that surround the NO producing cells. The white arrows indicate faintly stained multipolar cells which are surrounded 
by a plexus of blood vessels. (f) Example of the excellent signal to noise ratio obtained by the tungsten recording electrodes and the pattern of 
spikes shown by a primary‐like bushy cell. The red line shows the threshold for spike discrimination and the time of each resolved spike is shown 
by the dots at the top of the trace. (g–i) Low‐power views of the VCN cut in the coronal plane and stained for Nissl substance, nNOS and thallium 
uptake. This shows the numbers of neurones at a corresponding point in the posterior VCN stained by the three methods
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(A*) (A) (C)
(B*) (B)
(D)
(G) (H) (I)
(E)
(F)
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3.2 | Physiological characterization of units
Recordings were made from a total of 27 guinea pigs (17 
male, 10 female), resulting in 117 single‐unit recordings 
that were at least 1 hr long. Units where the spike ampli-
tude fell below the initial threshold level, before the end of 
the final recovery period, were discarded. After an initial 
identification of their CF and minimum threshold for ac-
tivation, all units were stimulated throughout the analysis 
period with 200 ms tone pips at a frequency correspond-
ing to their CF and at 20 dB above threshold (example in 
Figure  2f). Using these 200  ms tones we confirmed the 
unit response type as one of the four main physiological 
groups in the VCN as illustrated in Figure  3. The units 
were assigned to the physiological subgroups as follows: 
42 Choppers (Ch), 22 Primary‐like (Pr), 15 Phase‐locked 
(Ph), 18 Onset (On) and 20 Unclassified (Un). The pri-
mary‐like units (Figure  3a) showed an initial onset that 
decayed away rapidly to a steady firing rate and a smooth 
distribution of inter‐spike intervals (ISIs), while the onset 
units (Figure 3b) gave one or two spikes at the onset and 
then the spike probability dropped suddenly to a level 
close to 0. Their ISIs showed intervals of between 1 and 
2 ms between the first two spikes and then a wide but flat 
distribution of spike intervals thereafter. The chopper 
units (Figure 3c) had a distinctive, regular pattern of fir-
ing at the onset that gradually decayed away to a steady 
state. The ISI histogram showed a single peak that was 
usually for values of 2–3 ms followed by a gradually di-
minishing tail. The phase‐locked units (Figure 3d) showed 
very regular firing throughout the duration of stimulation 
and had an ISI that showed regular peaks at multiples of 
the stimulus waveform period (in this case 1  ms). The 
response type, as observed in the PSTH pattern, was not 
altered by administration of any of the drugs used in this 
study and remained stable throughout the analysis period 
even although there were sometimes large changes in the 
firing rate.
F I G U R E  3  (a–d) Examples of 
PSTHs from units illustrating the four main 
subgroups to which units were assigned. The 
CF of each unit is shown beneath its group 
name. The inter‐spike interval histogram for 
each unit is also shown as an insert with the 
coefficient of variation (CV) in the top right 
of each panel. The fifth subgroup consisted 
of the remainder of the units which did not 
easily fit into one of the above groups
T A B L E  1  The number of units recorded of each cell type, and the numbers of each unit type found to be responsive to drug applications
Note: The direction of the arrows indicates whether there was an increase or a decrease in the driven (D) or spontaneous (S) activity. Some units had changes in both 
driven and spontaneous activity (thin grey arrows) but most units only showed a change in one of these types of activity (thick black arrows).
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No strong associations between unit type and either 
L‐NAME, SIN‐1, SNOG or NMDA sensitivity were seen 
(Table 1). Effects observed during drug ejection were not 
cell‐type specific, as the proportions of unit types respon-
sive to each drug were similar to the proportion of unit types 
recorded from overall. A Fisher's exact test showed no sig-
nificant differences between the three main physiological 
groups (p = .284). Each physiological subgroup had at least 
one example that responded to one of the NO‐related drugs, 
but the low numbers of units responding to drugs meant that 
any weak effect would not be found. Overall, around 28% 
(24/85) of units in the VCN had firing rates modulated by 
NO‐related drugs (L‐NAME, SNOG or SIN‐1).
3.3 | Control experiments to 
confirm the effectiveness of the iontophoretic 
application of drugs
At the start of each track within the VCN, checks were 
made to confirm that the electrode assembly was working 
effectively before applying the NO‐related drugs. One of 
the pipette barrels was filled with 100 mM glutamate and 
current was applied to it (80 nA) to check that the micro-
pipette tips were within effective range of the recording 
tip of the electrode. Most units responded to glutamate 
with an increase in firing rate within 20  s of the cur-
rent being switched on. An example of this is shown in 
Figure 4a where glutamate was applied to a unit with a 
moderate spontaneous firing rate (8  sp/s) for a total of 
20 s. The firing rate increased within 15 s of the current 
being applied and remained high while the current was 
on. When the firing rate increased the spike amplitude 
progressively decreased. It then recovered to its previous 
amplitude and spontaneous firing rate over the next 20 s. 
The effects of glutamate were not quantified as its effects 
are well known and were not part of this study. However, 
they provided a useful comparison for control experi-
ments where buffered saline with the same pH as the NO‐
related drugs was applied from an adjacent pipette barrel 
at the same current strength (80 nA). An example of this 
is shown in Figure 4b where a salt solution (100 mM, pH 
8) was applied to a unit with a low spontaneous firing 
rate (1 sp/s) for 40 s without any effect on either firing 
rate or spike amplitude. We never saw any significant ef-
fect of current application using a salt solution with pH 
values of 4.5 or 8 using citrate or phosphate buffer and 
currents of 80 nA.
The biologically inactive isomer of L‐NAME, D‐NAME, 
was also used as a control. Over 100 min, 50 mM D‐NAME 
and L‐NAME were each applied at 80 nA for 20 min. This 
protocol was carried out on 15 VCN neurones from three 
animals (all female). L‐NAME caused a significant and re-
versible increase in driven firing rate in only two of these 
units and an example is shown in Figure  4c. By contrast, 
D‐NAME failed to produce a significant response in these 
two or any of the other units tested. In the example shown 
in Figure 4c there do appear to be small transient increases 
in firing rate during both the D‐NAME application periods. 
However, these appear to just be random fluctuations in the 
firing rate that were also present when no drug was being 
applied. Random fluctuations of this sort were also pres-
ent in other recorded units such as a few of those shown 
in Figure 5b. The periods analysed were the last 10 min of 
the response to D‐NAME and the firing rates then were not 
significantly different from the first and last 10 min of the 
F I G U R E  4  Two single‐unit recordings from VCN that show 
the spontaneous firing rate and spike amplitude over 1 min. In this 
and subsequent figures, the unit number is given in the bottom 
right hand corner of the panel. (a) Glutamate (100 mM, pH 8) was 
applied for 20 s at 80 nA (as indicated by the white bar) and after 
about 15 s. the firing rate increased and the spike amplitude started 
to decrease. (b) A salt solution (100 mM, pH 8) was applied for 40 s 
at 80 nA (white bar) without any effect on the firing rate or spike 
amplitude of the recorded unit. (c) A spike‐rate histogram of driven 
activity of a VCN neurone over 100 min showing no response to 
D‐NAME (red bars), but an increase in driven firing rate during 
L‐NAME application (green bar). Bin size 1 min. First spike latency 
was also recorded (pale line) 
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recording in Figure 4c. Thus only the L‐NAME application 
produced any significant changes.
3.4 | Firing rate changes in response to 
application of NO Donor (SIN‐1)
Figure 5 demonstrates that application of the NO donor SIN‐1 
caused dose‐dependent increases and decreases in firing rate 
of VCN units. Figure 5a shows the firing rate of a unit, in re-
sponse to the CF tone in 10‐s bins over 60 min, during which 
SIN‐1 was applied with three different ejection currents. It 
is clear that the SIN‐1 evokes an increase in the driven dis-
charge rate at all three ejection currents. It is also clear that 
the more SIN‐1 that is ejected the greater the increase in dis-
charge rate with no indication that this effect has saturated as 
the 120 nA ejection current produced a much larger increase 
than did the 80 nA. The firing rate increase develops slowly: 
it increases over the first 5 min or more of drug ejection and 
then stabilizes at a level that is ejection current dependent. 
After cessation of the ejection current the firing rate increase 
also subsides over several minutes. Figure 5c shows that, in 
other units, SIN‐1 can cause decreases to the spontaneous fir-
ing rate, that mirror those described above and show a similar 
ejection current dependency. The changes build up and sub-
side over similar time courses (i.e. over several minutes).
SIN‐1 was applied to a total of 25 units from four an-
imals (two male, two female). The effect of SIN‐1 on the 
driven firing rate of all these units is shown in Figure 5b. 
In this figure, each grey line indicates the data for one unit 
and the red lines show the data for the 5/25 (20%) units that 
showed significant increases in discharge rate. There were 
no units with a significant decrease in driven rate. The fact 
that the driven firing rate does not recover fully to the start-
ing baseline between current injections again shows that 
the effects are of long duration. Figure 5d shows changes in 
the spontaneous firing rate as a result of SIN‐1 application. 
Again, as for the driven rates, SIN‐1 evoked both increases 
and decreases in spontaneous rates in different units, but 
the changes were only consistent and hence significant for 
one unit where there was a reduced firing rate during drug 
application for all three drug concentrations (shown by the 
green line).
F I G U R E  5  (a, c) Spike‐rate histograms (bin size 10 s) of two VCN units over 1 hr. Three periods of SIN‐1 ejection at varying strength are 
indicated by the red horizontal bars. (a) Driven firing rate for a chopper unit with CF of 3 kHz. For driven firing rate, the first spike latency (FSL) 
averaged every 5 min is shown by the pale line. (c) Spontaneous firing rate for an Unclassified unit with CF of 12 kHz. (b, d) Mean driven and 
spontaneous firing rates of 25 VCN units during SIN‐1 application. Each line is data for one unit. The red lines in (b) and the green line in  
(d) show units in which the changes in spike rate with SIN‐1 application were statistically significant
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During the 120 nA ejection, the mean driven firing rate of 
the five units that increased went from a mean baseline rate of 
211 to 291 Hz (increased to 141.6% of baseline; SD = 28.9). 
These units were of two different types (4 Ch with CFs of 2.5, 
3, 8 and 12 kHz, 1 Pr with CF of 9 kHz; Figure 5b: red lines). 
A decrease from a baseline of 10.5 to 5.5 Hz (52.3% of baseline 
spontaneous firing rate) during 120 nA ejection of SIN‐1 was 
observed in one unit (Ph with CF of 1.6 kHz; Figure 5d green 
line). The first spike latency (FSL) was never affected by SIN‐1 
application. An example is shown by the pale line in Figure 5a.
To look for evidence that NO affects postsynaptic events, 
the shape of the extracellular spike was analysed for all data. 
The extracellular spike is an indirect measure of transmem-
brane potential, but should still reflect changes in membrane 
F I G U R E  6  (a, b) Spike amplitude (blue lines) and spike width (black lines) of two VCN units recorded over 1 hr, during three periods 
of increasing strength of SIN‐1 application. (c, d) Quantification of the increases observed in (a, b), respectively, with the data shown as the 
mean ± the standard error based on 10 s analysis periods as described previously. Comparisons between analysis periods were made using a 
Kruskal–Wallis test with Dunn's multiple comparison test. Significant changes are indicated by the presence of one or more asterisks. (d) Shows 
a significant increase in spike amplitude and width during SIN‐1 application, while (c) displays increased spike width with no alteration to spike 
amplitude. (e) Mean waveform of spikes during 5 min. of the baseline period and the last 5 min. of the SIN‐1 application at 80 nA for the unit 
shown in (a). The double‐headed arrows indicate the amplitude and width of the baseline spike. (f, g) Inter‐spike interval histograms of the unit 
shown in (b) during the second recovery period and the SIN‐1 application at 120 nA. The arrows mark the median values based on the first 20 ms 
of each response
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currents. The NO donor SIN‐1 produced an increase in the 
width of the extracellularly recorded spike shape in two chop-
per units (Figure 6) and both units showed increased driven 
firing rates in response to the SIN‐1. The first unit (Figure 6a) 
showed an increase in width (black line) in the presence 
of SIN‐1, while the amplitude was unaffected (blue line). 
However, the second unit (Figure 6b) showed a correlated in-
crease in both width and amplitude when SIN‐1 was applied. 
The effect of SIN‐1 on the first unit seemed to be maximal 
at an application level of 80 nA as increasing the current to 
120 nA did not produce a bigger effect (Figure 6c). By con-
trast, in the second unit there was a monotonic increase in 
both the width and height of the spike as the SIN‐1 levels 
increased (Figure 6d). The change in the shape of the spike il-
lustrated in Figure 6c is shown in Figure 6e which is the mean 
shape averaged over a period of 5 min. The slope of the depo-
larizing phase is less steep during the SIN‐1 application, im-
plying that the released NO affected the currents at the start of 
the spike (possibly NaV or KV1). In addition, the repolarizing 
phase of the spike is also delayed and this is consistent with 
an effect on voltage‐dependent potassium channels. Both of 
these units showed chopper responses, and we studied the 
ISI distribution of the first 20 ms of the response during the 
recovery period compared with the response during the end 
of the SIN‐1 application. For both units the median ISI de-
creased during the SIN‐1 application: for the second unit, the 
value decreased from 2.2 to 2 ms (Figure 6f,g). This change 
was significant for the second unit as shown by a two‐sample 
Kolmogorov–Smirnov test (p = .0436).
3.5 | Firing rate changes in response to 
application of NO donor (SNOG)
A total of 23 single units were recorded from during the 
iontophoretic ejection of SNOG and the results are sum-
marized in Table 1. Nine units (39%) showed a significant 
change in driven and/or spontaneous firing rate and all the 
main morphological types of neurone were affected. Both 
significant increases and decreases in the driven firing rate 
of chopper and primary‐like neurones were observed along 
with a decrease in the driven rate of an onset neurone and 
increases in two neurones of unspecified type. Of the six 
F I G U R E  7  (a, c) Spike‐rate histograms (bin size 10 s) of two VCN units over 1 hr. Three periods of SNOG ejection at increasing strength 
are indicated by the horizontal bars. (a) Driven firing rate for a chopper unit with CF of 17 kHz. The first spike latency averaged every 5 min is 
shown by the pale line. (c) Spontaneous firing rate for a primary‐like unit with CF of 12 kHz. (b, d) Mean driven and spontaneous firing rates of 
23 VCN units during SNOG application. Each line is data for one unit. The darker lines show units in which the changes in spike rate with SNOG 
application were statistically significant
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neurones showing a significant change in driven rate, three 
showed a mean increase from a baseline of 149  Hz to a 
rate of 256 Hz with the 120 nA injection level (170% in-
crease, SD 38.8) and three showed a mean decrease from 
a baseline of 112 Hz to a rate of 78 Hz with the 120 nA 
injection level (56.3%, SD 24.7). An example of SNOG 
increasing the driven rate of a chopper neurone is shown 
in Figure 7a. There was a significant effect of the SNOG 
at all three concentrations, but in this and other neurones 
(Figure 7b), the effects seemed to saturate at about 80 nA. 
Increasing the current to 120 nA did not significantly in-
crease the driven rate compared with 80 nA in any of the 
neurones. Spontaneous rate was also significantly altered 
by SNOG in the three main morphological types with both 
increases and decreases being observed in six neurones 
(Figure 7d). Of this six, four showed a mean increase from 
a baseline rate of 44  Hz to a rate of 163  Hz at an injec-
tion level of 120 nA (378%, SD 202.4) while two showed 
a decrease from a baseline of 39 Hz to a rate of 7 Hz at a 
level of 120 nA (20.2%, SD 7.4). Three of the units showed 
changes in both driven and spontaneous firing rates. An 
example of a primary‐like neurone where the spontane-
ous rate is significantly decreased by SNOG application is 
shown in Figure 7c. We did not record from any neurones 
with phase‐locked responses at CF and so did not check for 
an effect of SNOG on temporal precision but we did check 
for first spike latency changes. The first spike latency did 
vary by about ±10% over the recording period but there 
was never any significant correlation between first spike 
latency and SNOG application in any of the neurones.
3.6 | Firing rate changes as a result of 
application of NOS inhibitor L‐NAME
The exogenous NO provided by the SIN‐1 or SNOG supple-
ments the NO that is already being produced by the endog-
enous nNOS, and so, the neurones will potentially be exposed 
to unnaturally high levels of NO. An alternative way of look-
ing at the physiological effects of NO on the recorded neu-
rones is to block the endogenous nNOS. Thus measurements 
of firing rate over a period of 1 hr were used to identify the ef-
fect of the NOS inhibitor L‐NAME on VCN neurones. A total 
F I G U R E  8  (a, c) The driven and spontaneous spike‐rate histograms of two VCN single units, showing an increased driven rate (a; Ch with 
CF of 12 kHz) and decreased spontaneous rate (c; Un with CF of 10 kHz) in response to iontophoretic L‐NAME application. Bin size 1 min, 80 nA 
L‐NAME application is indicated by the red bar. The first spike latency (FSL) of the driven rate is shown by the blue line. (b, d) Mean driven and 
spontaneous firing rates of all 22 VCN units. Each grey line is the data for a single unit. Units showing statistically significant increases in spike 
rates are shown as darker continuous lines while those showing statistically significant decreases in spontaneous rate are shown by the dashed dark 
lines
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of 22 complete recordings, using L‐NAME alone, were made 
in nine animals (eight male, one female). L‐NAME clearly 
produced a change in both driven and spontaneous firing 
rates in a subpopulation of neurones, as shown in Figure 8. 
Over the course of the 1‐hr recording, only one application 
of L‐NAME was given and the firing rates were measured 
over 1‐min intervals. It is clear from the example shown in 
Figure 8 that the effect of L‐NAME on the driven rate takes 
a long time (20 min) to develop fully and a similar amount of 
time to dissipate. Out of the 22 units tested 4 (18%) showed 
a significant increase in firing rate during L‐NAME applica-
tion and this effect was reversed when the drug was no longer 
applied (dark lines in Figure 8b). The rise in the driven rate 
during L‐NAME application was quite large, with firing rates 
rising from a mean baseline of 53.6 Hz to a mean of 80.5 Hz 
(170.4%; SD = 35.3). The cell types and characteristic fre-
quencies of these 4 neurones were: Ch, 6 kHz; Ch, 12 kHz; 
Pr, 2.6 kHz; Un, 10 kHz. Two units also showed a large de-
crease in the driven rate after the L‐NAME was applied, but 
this effect did not reverse when the drug application stopped 
and thus we could not be sure that the reduction of the driven 
rate was a specific effect of the drug. There were also effects 
on the spontaneous rate and an example of a significant re-
duction is shown in Figure  8c where the change follows a 
similarly extended time course to the change in the driven rate 
described above. Out of the 22 single units recorded 2 (9%) 
showed a significant increase in mean baseline spontaneous 
rate of 4.6 to 9.7 Hz (to 178.9% of baseline, SD 47.7) during 
L‐NAME ejection and 2 (9%) showed a significant decrease 
in spontaneous rate from a baseline rate of 30.6 Hz to a rate of 
22 Hz (66.6% of baseline, SD 16.7). In all of these cases, the 
spontaneous rate returned to a level close to the baseline after 
the drug application was stopped (Figure 8d). The cell types 
and characteristic frequencies of these responsive neurones 
were: spontaneous rate increases (On, 12 kHz; Un, 10 kHz) 
decreases (Ch, 14.25 kHz; Un, 9.5 kHz). Changes in the driven 
firing rates on application of L‐NAME correlated with FSL: 
as driven firing rate increased, FSL decreased (Figure 8a, blue 
line). One of the unclassified units (Un) showed an increase 
in both driven and spontaneous activity (Table 1) but all the 
other affected units only showed a change in either the driven 
or spontaneous activity. Table  1 shows the combined units 
from the group where only L‐NAME was applied and the 
group where both L‐ and D‐NAME were applied.
To determine whether the L‐NAME had its effect 
throughout the duration of the CF‐tone‐driven response, the 
PSTHs during L‐NAME application were subtracted from 
the baseline PSTHs to calculate the difference in spike prob-
ability. An example set of baseline (Figure 9a) and L‐NAME 
(Figure 9b) PSTHs and the difference PSTH (Figure 9c) for 
a typically responsive unit shows that the facilitatory effects 
of the localized reduction in NO are slightly stronger during 
the first 50 ms of the response, but they continue throughout 
the duration of the tone pip. Large fluctuations in difference 
in spike probability are seen in the initial 20 ms of the driven 
period, likely due to a slight decrease in first spike latency 
altering the timing of the chopping pattern. The population 
data showed that, for all units in which the driven rate was 
affected by L‐NAME, the facilitation continued throughout 
the 200 ms driven period.
3.7 | Neither the NO donor SIN‐1 nor the 
NOS inhibitor affects phase locking
Low‐frequency units in the VCN are able to provide 
precise timing information about the period of a sound 
stimulus by locking their spikes to a particular phase of 
the sound wave. Changes in membrane conductances 
that might be produced by NO receptors could interfere 
with both the phase and strength of this temporal coding 
F I G U R E  9  (a) PSTH of the chopper unit from Figure 4a over 
the baseline period (10 min, sweeps 301–900; bin size 0.2 ms). (b) The 
PSTH of the same unit during L‐NAME application (10 min, sweeps 
1,501–2,100; bin size 0.2 ms). (c) The change in this PSTH during 
L‐NAME application (top–middle). A two‐sample Kolmogorov–
Smirnov test used to compare between the distributions showed they 
were significantly different (p < .01)
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and thus we sought evidence for these types of changes. 
Phase locking was only identified by stimulating units at 
CF (not in their low‐frequency tail) and was tested for 
all units with a CF below 5 kHz. A total of six units with 
phase‐locked responses were tested in the presence of L‐
NAME and a further six in the presence of SIN‐1. The 
first row of Figure 10 shows the distribution of spikes in 
a period histogram for a unit with excellent phase lock-
ing; a vector strength of over 0.7. This phase locking was 
unchanged by the application of L‐NAME. The lower row 
of Figure  10 shows the vector diagrams with the vector 
strength and phase angle indicated by the single dot. It is 
clear from these plots that L‐NAME did not change the 
magnitude nor the phase of the response of this unit. None 
of the 12 units showed significantly altered phase locking 
due to either drug application.
3.8 | Inhibition of NOS during NMDA‐
evoked excitation
Glutamate is the main excitatory transmitter in the VCN 
but there are different types of ionotropic and metabotropic 
receptors for glutamate in addition to the NMDA recep-
tors that can be directly linked to nNOS (Collingridge & 
Lester, 1989). In order to confirm that NMDA receptors 
are important in mediating the effects of NO in the VCN, 
NMDA was applied directly by iontophoresis along with the 
NOS blocker L‐NAME. The effect of L‐NAME on NMDA‐
mediated excitation was characterized in 32 recordings from 
seven animals (three male, four female; Table  1). NMDA 
evoked an increase in the spontaneous firing rate in 15/32 
(47%) of units with no correlation with cell type or initial 
spontaneous rate. The NMDA was introduced in trains of 
five applications, each lasting 1 min. The first application 
of current usually had little or no effect, and even in re-
sponsive units, there were often just four bursts of increased 
activity as shown in the last 10 min of Figure 11a. These 
bursts of increased spontaneous activity were enhanced 
by the application of L‐NAME in six units (40%; darker 
lines Figure  11d). These increased firing rates were seen 
in both low (Figure  11a) and high spontaneous rate units 
(Figure 11c). In three units, the application of L‐NAME im-
mediately following the initial NMDA bursts induced firing 
rate increases at the onset of the L‐NAME even when the 
NMDA was no longer being applied (seen in Figure 11a as 
activity marked by the *).
Of the 15 units that were NMDA‐sensitive, L‐NAME 
application enhanced NMDA excitation during the driven 
period in 3 (20%) units and reduced excitation in 1 (7%; 
Figure  11b). The effects of L‐NAME on some individual 
F I G U R E  1 0  Phase‐locking analysis of a 400 Hz unit during the three analysis periods: Baseline, L‐NAME and Recovery (columns left to 
right). Top row: Period histograms for spikes during each of the three analysis periods. Bottom row: polar plots showing individual spikes as blue 
dots around the edge. Vector strength (VS; length along radius) and characteristic phase (degrees) are indicated by the red circle. No changes in 
vector strength or timing are observed between the three analysis periods
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neurones were quite large but overall L‐NAME only had an 
effect on a small proportion of neurones (9/37; 24%).
4 |  DISCUSSION
The effects of NO on the activity of single neurones in 
the VCN has not been studied in vivo before, although 
there has been a recent study on patch clamped neurones 
in mouse brain slices (Cao et  al., 2019). Thus our main 
purpose was to initially establish what effect NO has in 
the intact VCN rather than to investigate the mechanisms 
of action. The main result was that only about 25% of neu-
rones in the VCN responded to a change in NO levels. 
This roughly corresponds to the proportion of neurones 
that contain measurable amounts of nNOS. However, the 
link between these two numbers is not immediately appar-
ent. At physiological levels, the NO is thought to act on 
its main receptor which is guanylyl cyclase (Garthwaite, 
2019). The distribution of nNOS and guanylyl cyclase may 
not be the same. Their distribution in the VCN has been 
compared in the rat and most principal neurones contained 
both nNOS and guanylyl cyclase, except for OC which 
apparently did not contain guanylyl cyclase (Burette et al., 
2001). The auditory nerve fibres also lacked significant 
amounts of guanylyl cyclase and this implies that NO 
would not be acting as a retrograde messenger via cGMP. 
Thus although spiral ganglion neurones are known to con-
tain nNOS (Burette et  al., 2001; Fessenden et  al., 1999) 
and we saw evidence of nNOS in presynaptic terminals, 
NO produced by the nerve fibres may have a different tar-
get. One such target is hyperpolarization‐activated, cyclic 
nucleotide‐dependent membrane channels (HCN1 Kopp‐
Scheinpflug et al., 2015) which can be modified indepen-
dently of the cGMP pathway.
In the VCN, nNOS is mostly located postsynaptically 
and, although it mainly appeared to be cytoplasmic, there 
was also evidence of small patches on the postsynaptic 
F I G U R E  1 1  (a, c) Spike‐rate histograms of two VCN units which both displayed an increase in spontaneous firing rate during 1 min bursts 
of NMDA application (green bars). Enhancement of this NMDA‐evoked excitation occurred during the 20‐min L‐NAME application (red bars) 
for units with low (a) and high (c) spontaneous rates. Bin size = 10 s. (b, d) The percentage of baseline driven and spontaneous firing rates evoked 
by NMDA bursts before, during and after L‐NAME application. Log% was used for spontaneous firing rate increases due to the very low baseline 
firing rates in some units. Significant increases and decreases are highlighted by red and green lines, respectively. Black dotted line marks 100% 
(no change) 
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membrane. There are three alternative splice forms of nNOS 
(α, β, γ) that are characterized by different exons (Lee, Cai, 
Hubner, Lee, & Lindpaintner, 1997). The major type in the 
VCN is the β form (Eliasson et al., 1997), which is located 
in the cytoplasm and lacks an initial pdz domain that would 
allow it to bind to the postsynaptic density protein (PSD‐95 
Brenman, Xia, Chao, Black, & Bredt, 1997). However, there 
is also some of the α variant which does have an initial pdz 
domain and can bind to the PSD‐95 protein along with the 
NMDA receptor to form a multi‐protein complex that in-
cludes guanylyl cyclase (Olthof‐Bakker et al., 2019). In our 
study, almost half of the neurones responded to exogenous 
NMDA and seemed to have functional receptors. The mem-
brane‐bound nNOS can be activated by calcium entering via 
the NMDA channel to give a localized increase in cGMP. 
One of the nearby membrane targets for cGMP is a volt-
age‐dependent potassium channel (Kv3.1) which is present 
in bushy cells (Rusznák et al., 2008) and some stellate cells 
of the VCN (Perney & Kaczmarek, 1997). NO is a modula-
tor of potassium channels (Artinian,Tornieri, Zhong, Baro, 
& Rehder, 2010) and they regulate the excitability of VCN 
neurones (Cao, Shatadal, & Oertel, 2007; Rothman & Manis, 
2003).
NO was unequivocally shown to have an action in the au-
ditory nervous system in two papers by Steinert et al. (2008, 
2011). In the first paper, they demonstrate that NO inhi-
bition of Kv3 potassium channels in the MNTB produces 
a widening of the action potential (Steinert et  al., 2008), 
which in turn results in more sustained depolarization, 
and inactivation of voltage‐gated sodium channels, hence 
reducing gain and information transmission. In the subse-
quent paper (Steinert et  al., 2011), the authors show that 
as well as suppression of the Kv3 channels, Kv2 channels 
are facilitated. This raises spiking threshold and increases 
fidelity (and hence rate) of firing by reducing failures. Kv2 
channels seem, at the very least, to be much less extensively 
expressed in VCN, but a very wide range of other potas-
sium channels are certainly present (Friedland, Eernisse, & 
Popper, 2007). Despite this, we only found evidence of ei-
ther spike widening or change in spike amplitude in two out 
of 94 neurones where NO levels were manipulated. Both of 
these neurones showed chopping responses and there may 
be a significant association between the distinct membrane 
channels associated with chopping (Oertel, Wright, Cao, 
Ferragamo, & Bal, 2011) and the NO induced change in 
spike shape. One of the neurones showed a decreased slope 
during the depolarization phase of the spike and this is con-
sistent with an effect of NO on sodium channels as shown 
in the MNTB (Steinert et al., 2008). Despite the widening 
of the spike shape both of these neurones also showed a 
decrease in the median ISI during the initial chopping phase 
that is consistent with an increased firing rate in response 
to acoustic stimuli. By contrast, none of the neurones with 
phase‐locked responses showed any NO induced change in 
temporal fidelity or spike shape.
Most of the nNOS in the VCN is located in the cytoplasm 
of the principal cell somata (Coomber et al., 2015). The cy-
toplasmic nNOS may also be activated by calcium from the 
NMDA channels or released from other sources following 
depolarization (Garthwaite, 2008; Steinert et al., 2011). The 
most striking effect of endogenous NO on VCN neurones was 
the suppression of spike rate during acoustic driving where 
16% (6/37) of neurones showed a mean increase of 170% in 
driven firing rate when NO synthesis was inhibited by apply-
ing L‐NAME. This appears to represent a feedback inhibi-
tion of NMDA receptors which has previously been shown 
to be long‐lasting (Manzoni et  al., 1992) and may involve 
S‐nitrosylation (Ahern, Klyachko, & Jackson, 2002; Chen, 
Jin, & Pan, 2017). The levels of NO produced by nNOS are 
not normally enough to produce nitrosylation (Garthwaite, 
2008), but the dense cytoplasmic nNOS and high mean rates 
of firing apparently can lead to a build‐up of NO levels suf-
ficient to directly modify protein thiol groups. Even in si-
lence some auditory nerve fibres have spontaneous rates of 
up to 120 Hz (Tsuji & Liberman, 1997) and with NO having a 
half‐life of between 7 and 630 ms (Garthwaite, 2019; Santos, 
Lourenço, Ledo, Barbosa, & Laranjinha, 2012) there could 
still be a steady build‐up of NO levels as shown in slices of 
the SOC (Steinert et al., 2008). This explanation is strength-
ened by the results from the direct application of NMDA 
where some neurones showed a higher firing rate in response 
to the NMDA when L_NAME was inhibiting the endogenous 
production of NO compared with baseline levels. This pre-
sumably reflects an effect of endogenous NO similar to the 
reduction in spontaneous rate induced by SIN‐1 (Figure 5c), 
that is endogenous NO was holding the spontaneous firing 
rate down and the inhibition of its production by L‐NAME 
enables a larger response to the NMDA. In Figure 11a the 
NMDA responses are reduced following the cessation of L‐
NAME possibly reflecting a recovery of the effectiveness of 
the endogenous NO.
Different mechanisms of action must be involved when 
exogenous NO (SIN‐1 or SNOG) were applied as they were 
capable of increasing or decreasing both driven and spon-
taneous activity. Unfortunately, given the long time course 
of the effects of the applied drugs, we were unable to apply 
SIN‐1 or SNOG and L‐NAME sequentially to the same neu-
rone. Thus, we do not know if the neurones which increased 
their firing rate in the presence of L‐NAME (reduced NO 
levels), would also have increased their firing rate in the 
presence of a NO donor. It is possible, and indeed likely, 
that the neurones with opposite responses to NO formed 
separate populations. We divided our cells into a minimum 
number of classes but bushy cells (Cao et  al.,2007), onset 
cells (Arnott et al., 2004) and choppers (Palmer et al., 2003; 
Rhode et  al., 1983) can all be subdivided into different 
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subclasses in terms of both their physiological properties 
and axonal projections. They can also differ in neurotrans-
mitter type: one type of small stellate cell with chopper re-
sponses is thought to be glycinergic (Ngodup & Trussell, 
2019) while most choppers are thought to be glutamatergic. 
The T‐stellate chopper cells of the mouse VCN form a bidi-
rectional, positive feedback network that is dependent on NO 
(Cao et  al.,2019). Glutamatergic interneurones apparently 
connect the T‐stellate cells and retrograde NO messaging 
at either of the input/output synapses of the interneurones 
can potentiate the release of glutamate and increase the gain 
applied to auditory signals passing through the T‐stellates. 
Conversely, if glycinergic neurones with local axons were 
also subject to NO based facilitation then they could cause 
a decrease in the gain of their local targets. NO can exert 
different effects depending on whether it interacts with neu-
rotransmitter specific receptor complexes or voltage‐depen-
dent ionic channels and its role within the brain appears to 
be very complex.
An additional factor in this complexity may be that there 
are micro‐compartments in the VCN that have very different 
ambient levels of NO. There is a wide range of staining inten-
sity for nNOS in individual neurones of the VCN, but there is 
also a range of densities of nNOS containing neurones with 
some densely packed and some relatively isolated (Coomber 
et al., 2015). The mobility of NO and its action as a volume 
transmitter (Artinian et  al., 2010) allows the regulation of 
neurones even if they do not generate NO themselves (Steinert 
et al., 2008). Some of this ambient NO may be produced by 
endothelial cells (Garthwaite, 2008). However, while the NO 
can freely diffuse in brain slices in vitro, the major mecha-
nism for inactivating NO in vivo is the haemoglobin that is 
being pumped through a dense network of blood vessels in 
the VCN (Figure 2e, Santos et al., 2012). This may mean that 
the blood vessels form a meshwork that produces relatively 
isolated compartments. As a result, some neurones may be 
exposed to very low levels of NO even if they are very active, 
while others may be exposed to high levels of NO even if they 
are relatively inactive.
A further complication is the presence of the urethane 
anaesthetic, which is liable to affect the function of NO di-
rectly. The effects of anaesthesia are more of a concern at 
the higher levels of the auditory system and we have used 
chronic implants in our guinea pigs to record evoked po-
tentials at the level of the auditory cortex and brainstem in 
awake guinea pigs (Berger, Coomber, Wallace, & Palmer, 
2017) and compared them with anaesthetized. Anaesthesia 
does have an effect on the cochlear nucleus but it is more 
pronounced in the dorsal part. Activity in the VCN is af-
fected to a lesser degree and the level of activity is re-
markably resistant to anaesthesia (Evans & Nelson, 1973). 
However, there will be some effects partly due to descending 
inputs from the olivocochlear pathway. Very few recordings 
are made from the VCN in awake animals because it is dif-
ficult to gain access to it in a chronic preparation. It is not 
possible to be sure what effect the anaesthetic will have on 
the NO‐related drugs. Our main interest in the results is to 
compare them with results from animals that have developed 
tinnitus. A comparative study of that sort is less affected by 
anaesthesia than one designed to study the interactions be-
tween neurones in an alert animal.
Another potential confounding factor is the presence of 
different levels of reproductive hormones depending on the 
sex of the animal. There is some evidence that prolonged ex-
posure to oestrogen and progesterone may influence the lev-
els of nNOS in cortical neurones (Mannella, Sanchez, Giretti, 
Genazzani, & Simoncini, 2009). With all of our drugs, except 
SNOG, we used a mixture of male and female animals and 
overall sex should not have had much effect on our conclu-
sions. With the SNOG results, all the animals were male and 
so fluctuating female hormone levels would not have been 
an issue. We were not aware of any effects in our results that 
might have been caused by differences in sex but the small 
numbers of neurones showing any particular effect means 
that we cannot rule it out entirely.
In the VCN, iontophoretic L‐NAME application (re-
duced NO levels) produced either increased or decreased 
spontaneous rates in about equal proportions. However, the 
tendency for L‐NAME to reduce high spontaneous rates 
and increase low spontaneous rates (Figure 8) suggest that 
the presence of NO is not acting to bring firing levels to-
wards a long term mean value for a whole population, but 
rather is maintaining the range of spontaneous rates within 
the population. In other systems, NO has been shown to 
either increase or decrease spontaneous rates (Clasadonte, 
Poulain, Beauvillain, & Prevot, 2008; Kim et  al., 2004; 
Podda et al., 2004), so the variable effect observed here is 
not unexpected.
In conclusion, our results show that some 16% of VCN 
neurones are under tonic suppression of their firing rate, 
while responding to acoustic stimulation, due to sustained 
effects of endogenous NO. The ambient levels of NO are 
also able to either facilitate or suppress the background fir-
ing rate, but this seems to affect less than 10% of neurones. 
However, other neurones (about 20%) show facilitation 
of their driven firing when exogenous NO is applied and 
potentially these neurones could be affected by a change 
in ambient NO levels that is thought to occur after noise 
exposure or the development of tinnitus (Coomber et  al., 
2014, 2015). Our previous work indicated that nNOS levels 
may increase in the VCN on the side that is exposed to high 
levels of unilateral noise while decreasing on the non‐ex-
posed side. The functional effects may be complicated and 
we intend to study them directly in future in animals that 
have been noise‐exposed and then have gone on to develop 
tinnitus.
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